LAURA WIEBER: Open Payments
NPI 1013311901 · PRINCETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 13 payments from 12 companies in 2025. Trend: 2023 $1,803 · 2024 $1,192 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| KYOWA KIRIN, INC. | 2 | $242 |
| BeOne Medicines USA, Inc. | 1 | $130 |
| GENZYME CORPORATION | 1 | $112 |
| JAZZ PHARMACEUTICALS INC. | 1 | $89 |
| Fennec Pharmaceuticals, Inc. | 1 | $25 |
| TerSera Therapeutics LLC | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| TAIHO ONCOLOGY, INC. | 1 | $19 |
| Coherus Oncology, Inc. | 1 | $19 |
Products named: POTELIGEO, BRUKINSA, SARCLISA, RYLAZE, Fyarro, Zoladex, VENCLEXTA, OPDIVO.
Industry payments across NJ — which companies pay providers there.
